SENEXON-S (docusate sodium 50 mg sennosides a and b 8.6 mg) Dailymed
Generic: docusate sodium -sennosides
IMPRINT: TCL081
SHAPE: round
COLOR: orange
Go PRO for all pill images
Otc - Active Ingredient Section
Active ingredients (in each tablet)
Docusate sodium 50 mg
Sennosides 8.6 mg
Warnings Section
Do not use if your are taking mineral oil; for longer than one week; when abdominal pain, nausea or vomiting are present
Otc - Keep Out Of Reach Of Children Section
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Otc - Purpose Section
Uses: relieves occasional constipation; generally produces bowel movement in 6-12 hours.
Inactive Ingredient Section
Inactive ingredients
carnauba wax, colloidal silicon dioxide, croscarmellose sodium
D-C yellow #10 aluminum lake, dibasic calcium phosphate dihydrate, FD-C yellow #6 aluminum lake, hypromellose,magnesium stearate, microcrystalline cellulose, polyethyleneglycol, sodium benzoate, stearic acide, Titanium dioxide
Dosage & Administration Section
Dosage and Administration
Adults and children 12 years and over - 2 tablets once a day - maximum dosage - 4 tablets twice a day
children 6 to under 12 years - 1 tablet once a day maximum dosage - 2 tablets twice a day
children 2 to under 6 years - 1/2 tablet once a day - maximum dosage- 1 tablet twice a day
children uner 2 years - ask a doctor
Indications & Usage Section
RELIEVES OCCASIONAL CONSTIPATION
GENERALLY PRODUCES BOWEL MOVEMENT IN 6-12 HOURS
Package Label.principal Display Panel
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
